 |
20 Diseases |  |
0 Trials |
|
0 Trials |  |
11 News |  |
- |||| JNJ 49095397 / J&J
Trial completion, Trial primary completion date: An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (clinicaltrials.gov) - Sep 30, 2014
P2, N=211, Completed, Sponsor: Janssen Research & Development, LLC
Active, not recruiting --> Completed | Trial primary completion date: Jan 2015 --> Aug 2014
- ||| JNJ 49095397 / J&J
Enrollment closed: An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (clinicaltrials.gov) - May 28, 2014
P2, N=211, Active, not recruiting, Sponsor: Janssen Research & Development, LLC
Active, not recruiting --> Completed | Trial primary completion date: Jan 2015 --> Aug 2014 Recruiting --> Active, not recruiting
- |||| JNJ 49095397 / J&J
Enrollment open: An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (clinicaltrials.gov) - Aug 21, 2013
P2, N=200, Recruiting, Sponsor: Janssen Research & Development, LLC
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- ||||| JNJ 49095397 / J&J
New P2 trial: An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (clinicaltrials.gov) - Jun 2, 2013
P2, N=200, Recruiting, Sponsor: Janssen Research & Development, LLC
- | JNJ 49095397 / J&J
Trial completion: A Study to Investigate the Safety and Tolerability of a New Inhaled Formulation of RV568 in Healthy Volunteers (clinicaltrials.gov) - Feb 28, 2013
P1, N=50, Completed, Sponsor: Respivert Ltd
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | JNJ 49095397 / J&J
New P1 trial: A Study to Investigate the Safety and Tolerability of a New Inhaled Formulation of RV568 in Healthy Volunteers (clinicaltrials.gov) - Aug 7, 2012
P1, N=50, Completed, Sponsor: Respivert Ltd
- | JNJ 49095397 / J&J
Trial completion: A Study to Investigate How Safe and Well Tolerated RV568 is in Patients With Chronic Obstructive Pulmonary Disease (COPD) (clinicaltrials.gov) - May 1, 2012
P2, N=30, Completed, Sponsor: Respivert Ltd
Active, not recruiting --> Completed Recruiting --> Completed
- | JNJ 49095397 / J&J
New P2 trial: A Study to Investigate How Safe and Well Tolerated RV568 is in Patients With Chronic Obstructive Pulmonary Disease (COPD) (clinicaltrials.gov) - Nov 15, 2011
P2, N=30, Completed, Sponsor: Respivert Ltd